Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	712.20	63.93	7.87
Graham Fair Price	-43.05	0.78	1.36
PEG	inf	0.00	0.23
Price/Book	171.02	0.68	-0.25
Price/Cash Flow	-12.10	7.15	8.14
Prices/Earnings	12.10	-0.68	-0.77
Price/Sales	-12.10	1.86	2.12
Price/FCF	-12.10	7.15	8.14
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.36	0.36
Operating Margin	0.00	-0.02	-0.02
ROA	0.00	-0.06	-0.06
ROE	0.08	-0.25	208.33
ROIC	< 0.005	< 0.005	-23.67
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.00	-1.00	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.09	0.00	inf
EPS QOQ	0.03	0.00	inf
FCF QOQ	-0.52	0.00	inf
Revenue QOQ	0.04	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	64.50	64.50	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	1.40	1.40	0.00
Debt/Capitalization	-0.02	0.75	4102.81
Quick Ratio	0.13	0.27	114.58
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	-1.01	0.33	-67.57
Cash	0.14	0.29	114.58
Capex	< 0.005	< 0.005	0.00
Free Cash Flow	0.03	0.03	0.00
Revenue	0.12	0.12	0.00
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.39	0.39	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-7.37	50.54	585.95
Naive Interpretation	Member

06 - Financial Health · Bad

Rating